Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NUF2 is associated with cancer stem cell characteristics and a potential drug target for prostate cancer. | Front Mol Biosci | 2024 | 39703688 | PubTator, text mining | PubMed |
| Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis. | Int J Mol Sci | 2024 | 39684488 | PubTator, text mining | PubMed |
| Ubiquitination-Binding Enzyme 2C is Associated with Cancer Development and Prognosis and is a Potential Therapeutic Target. | Onco Targets Ther | 2024 | 39678016 | PubTator, text mining | PubMed |
| The mechanism underlying B-cell developmental dysfunction in Kawasaki disease based on single-cell transcriptomic sequencing. | Front Immunol | 2024 | 39507528 | PubTator, text mining | PubMed |
| UBE2C, targeted by miR-140-3p, promotes the progression of osteosarcoma via PI3K/AKT signaling pathway. | J Recept Signal Transduct Res | 2024 | 39499012 | PubTator, text mining | PubMed |
| SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling. | Open Life Sci | 2024 | 39479352 | PubTator, text mining | PubMed |
| Exploring Potential Biomarkers and Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma Based on Bioinformatics. | Onco Targets Ther | 2024 | 39479232 | PubTator, text mining | PubMed |
| UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathway. | Discov Oncol | 2024 | 39448441 | PubTator, text mining | PubMed |
| Gene expression profile analysis of severe influenza-based modulation of idiopathic pulmonary fibrosis. | Eur J Med Res | 2024 | 39420432 | PubTator, text mining | PubMed |
| Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology. | Front Med (Lausanne) | 2024 | 39371335 | PubTator, text mining | PubMed |
| The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma. | Sci Rep | 2024 | 39353974 | PubTator, text mining | PubMed |
| Multi-Omics Exploration of the Mechanism of Curcumol to Reduce Invasion and Metastasis of Nasopharyngeal Carcinoma by Inhibiting NCL/EBNA1-Mediated UBE2C Upregulation. | Biomolecules | 2024 | 39334908 | PubTator, text mining | PubMed |
| Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers. | Int J Biol Sci | 2024 | 39309447 | PubTator, text mining | PubMed |
| Ailanthone suppresses cell proliferation of renal cell carcinoma partially via inhibition of EZH2. | Discov Oncol | 2024 | 39298003 | PubTator, text mining | PubMed |
| Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer. | Int J Mol Sci | 2024 | 39201599 | PubTator, text mining | PubMed |
| Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization. | Biochem Biophys Res Commun | 2024 | 39151295 | PubTator, text mining | PubMed |
| Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches. | Medicine (Baltimore) | 2024 | 39093763 | PubTator, text mining | PubMed |
| Discovery of differentially expressed proteins for CAR-T therapy of ovarian cancers with a bioinformatics analysis. | Aging (Albany NY) | 2024 | 39033780 | PubTator, text mining | PubMed |
| UBE2C regulates the KEAP1/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy. | Int J Biol Macromol | 2024 | 39032892 | PubTator, text mining | PubMed |
| Establishment of diagnostic model and identification of diagnostic markers between liver cancer and cirrhosis based on multi-chip and machine learning. | Clin Exp Pharmacol Physiol | 2024 | 38965675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=8